Borderline resectable pancreatic cancer: A consensus statement by the International Study Group of Pancreatic Surgery (ISGPS)

2014/02/07 by Maximilian Bockhorn, Faik G. Uzunoglu, Faik G. Uzunoǧlu +33 · 3 citations
Medicine · #Pancreatic and Hepatic Oncology Research #Inflammatory Biomarkers in Disease Prognosis #Pancreatitis Pathology and Treatment

paper · doi:10.1016/j.surg.2014.02.001

Cited by

• Peptide receptor radionuclide therapy as neoadjuvant therapy for resectable or potentially resectable pancreatic neuroendocrine neoplasms
• Periadventitial dissection of the superior mesenteric artery for locally advanced pancreatic cancer: Surgical planning with the “halo sign” and “string sign”
• Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up